SRF’s persistent pain point hampers investors’ confidence on earnings outlook

October 23, 2026

2

The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27The management reiterated its 15-20% revenue growth guidance for the chemicals business and expects to deliver at the higher end of the range in FY27

SRF’s persistent pain point hampers investors’ confidence on earnings outlook

Related Articles

Investors are starting to find opportunities in the battered bond market

Qatar deal to buy U.S. natural gas shows how Iran war has redrawn global energy markets

U.S. dropping some Canada tariffs, Susan Collins says as trade war looms over Maine Senate race

Latest Articles

Investors are starting to find opportunities in the battered bond market

Qatar deal to buy U.S. natural gas shows how Iran war has redrawn global energy markets

U.S. dropping some Canada tariffs, Susan Collins says as trade war looms over Maine Senate race

Ukraine Officials Complain Starshield Restrictions Still Not Lifted, Despite Trump Assertions

New York City Votes To Ban Horse-Drawn Carriages, Ending 170-Year Tradition